Navigation Links
EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations

Online feedback platform will remain open until March 21, 2008

HOUSTON, March 3 /PRNewswire-USNewswire/ -- Using the same process as government agencies when implementing new policies, a national alliance of scientists, public health leaders, and community representatives today called for public comment on a series of proposals designed to eliminate continued disparities in U.S. clinical trials.

As part of the four year initiative, Eliminating Disparities in Clinical Trials (EDICT), a project jointly conducted by Baylor College of Medicine's Chronic Disease Prevention and Control Research Center and the Intercultural Cancer Council, the alliance created a new Web-based portal so policy makers, patient advocates, research scientists and industry members can review the proposals developed to improve clinical trials patient recruitment and retention in medical research studies. The public comment period closes on March 21, 2008.

On April 1, EDICT will issue its final policy recommendations in Washington, DC.

"A variety of systemic, cultural and psychosocial barriers prevent participation by underrepresented populations, including women, adolescents, older adults, racial and ethnic minorities, those with disabilities, in rural areas and others," said Armin D. Weinberg, Ph.D., Director of Baylor College of Medicine's Chronic Disease Prevention and Control Research Center and EDICT's Principal Investigator.

More than 300 representatives of public, private and non-profit stakeholders catalogued the most significant barriers to participation, examined current policies related to clinical trials, identified opportunities for policy change that would address those barriers, and developed practical and realizable policy solutions to clinical trial disparities at the federal, state and institutional levels in the public, private and non-profit sectors.

"Our policy research has demonstrated the importance of involving the broadest possible set of stakeholders as part of this process. To date, we had input from across all stakeholder groups involved in clinical trials. We are now seeking input from the public at large. We hope that interested individuals and those representing concerned populations will review the policy change recommendations and provide feedback," Weinberg said.

To review the policy recommendations and provide feedback, go to

EDICT Credo:

-- Everyone should have the opportunity and necessary support to participate voluntarily in clinical trials for which they are eligible.

-- Participants and researchers should understand the benefits of diversity in clinical trials.

-- Results from clinical research should benefit the participants' communities and society at large.

The EDICT (Eliminating Disparities in Clinical Trials) Project was created by Baylor College of Medicine's Chronic Disease Prevention and Control Research Center with the Intercultural Cancer Council and supported by an unrestricted educational grant from Genentech, Inc.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Simple Test Accurately Predicts Risk of Serious Jaundice in Newborns
2. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
3. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
4. DNA Test Predicts Harmful Effects of Cancer Drug
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
7. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
8. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
9. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
10. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
11. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
Post Your Comments:
(Date:11/26/2015)... 2015 --> ... combineert immunotherapie met Bremachlorin-photodynamische therapie voor de ... ) --> ... ) Uit een ... (LUMC) blijkt dat ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "2016 Future Horizons ... of Abuse Testing Market: Supplier Shares, Country ... report to their offering. --> ... the "2016 Future Horizons and Growth ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, ... new Wimbledon Athletics Facebook page to educate the public, parents and ... abnormalities. About 2,000 people under the age of 25 die from sudden cardiac ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for the ... of the benefits of Botox® in the treatment of moderate facial wrinkling, few have ... pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism (the ...
(Date:11/25/2015)... ... 2015 , ... Brillianteen, McGaw YMCA’s student-produced musical show, will ... Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions for this final production ... been a treasured tradition for numerous families in the Evanston community. Over the ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I ... regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order ... developed the patent-pending RECOVERY BRA for added comfort and support. The bra is ...
Breaking Medicine News(10 mins):